Literature DB >> 3604263

Dose-dependent pharmacokinetics of cimetidine in the rat.

A Adedoyin, L Aarons, J B Houston.   

Abstract

The pharmacokinetics of cimetidine were studied in the rat after intraperitoneal administration of 10, 40 and 100 mg/kg. The area under the plasma concentration-time curve increased more than proportionately with dose. The total plasma clearance of cimetidine decreased as the dose increased (4.11 to 2.21 l/h per kg) with a consequent increase in half-life (24.0 to 37.9 min) but no change in volume of distribution (mean 2.31 l/kg). The fraction of dose excreted unchanged increased slightly with dose (0.37 to 0.45), whereas the fraction excreted as the sulphoxide metabolite decreased significantly with increased dose (0.35 to 0.14). Both the renal clearance (1.52 to 0.99 l/h per kg) and the formation clearance of the sulphoxide metabolite (1.45 to 0.30 l/h per kg) decreased with increasing dose. Residual clearance, calculated as the difference between total clearance and the sum of renal and metabolic clearance, did not change with dose (mean 1.08 l/h per kg). The formation clearance of the sulphoxide metabolite became saturated at a lower cimetidine concentration than the renal clearance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3604263     DOI: 10.3109/00498258709043966

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  Disposition of azole antifungal agents. I. Nonlinearities in ketoconazole clearance and binding in rat liver.

Authors:  D Matthew; B Brennan; K Zomorodi; J B Houston
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

2.  Time-dependent disposition of beta-naphthoflavone in the rat.

Authors:  A Adedoyin; L Aarons; J B Houston
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

3.  Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).

Authors:  Martina Ceckova; Josef Reznicek; Birgit Deutsch; Martin F Fromm; Frantisek Staud
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

4.  Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats.

Authors:  Yoo-Seong Jeong; Anusha Balla; Kwang-Hoon Chun; Suk-Jae Chung; Han-Joo Maeng
Journal:  Pharmaceutics       Date:  2019-03-06       Impact factor: 6.321

Review 5.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

6.  Determinants of drug entry into the developing brain.

Authors:  Liam Koehn; Mark Habgood; Yifan Huang; Katarzyna Dziegielewska; Norman Saunders
Journal:  F1000Res       Date:  2019-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.